This article reviews current trends in the treatment of osteoid osteoma, with an emphasis
on the evolving use of radiofrequency thermoablation as a primary definitive treatment
and for recurrent and residual lesions. In so doing, the article reviews the merits
and relative disadvantages of both surgical and nonsurgical imaging-guided techniques
in treatment. Radiofrequency ablation of osteoid osteoma is a highly effective, efficient,
minimally invasive and safe method of treating osteoid osteoma. Clinical success range
from 76% to 100%. Surgery remains the standard treatment in cases where histology
of the lesion is in doubt, neurovascular structures are within 1.5 cm or in repeated
failure of any other minimally invasive ablative technique or percutaneous resection.
Clinical success of surgery ranges from 88% to 100%. Laser interstitial thermal therapy
shares many of the advantages and much of the success of radiofrequency thermoablation
but has not been as available. Clinical success ranges from 87% to 100%. Cryotherapy,
ethanol therapy and imaging-guided excision remain second-line therapies. Clinical
success ranges from 77% to 100% for imaging-guided resection and 100% for ethanol
therapy.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinical ImagingAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
Published online: August 19, 2004
Eur Radiol 2004;14:607–617Identification
Copyright
© 2004 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
